Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to evaluate the efficacy and safety of a controlled release formulation of pregabalin administered once daily as compared to placebo in the treatment of fibromyalgia. All patients will receive pregabalin; half of the patients will receive placebo at some point in the study.

Key facts

Study ID

NCT01271933

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

441

Starts

2011-03-01

Expected to finish

2012-07-01

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have fibromyalgia.

You may not qualify if…

• Patients with other painful conditions cannot participate.

Where it is running

• Apex Research Institute — Santa Ana, California, United States
• Paddock Park Clinical Research — Ocala, Florida, United States
• Broward Research Group — Pembroke Pines, Florida, United States
• Meridien Research — Tampa, Florida, United States
• Arthritis Care Center — Moline, Illinois, United States
• Davis Clinic, Inc — Indianapolis, Indiana, United States
• Central Kentucky Research Associates, Inc. — Lexington, Kentucky, United States
• Commonwealth Biomedical Research, LLC — Madisonville, Kentucky, United States
• Boston Clinical Trials — Boston, Massachusetts, United States
• Beacon Clinical Research, LLC — Brockton, Massachusetts, United States
• The Center for Pharmaceutical Research, PC — Kansas City, Missouri, United States
• Mercy Health Research — St Louis, Missouri, United States
• Quality Clinical Research, Inc. — Omaha, Nebraska, United States
• AB Clinical Trials — Las Vegas, Nevada, United States
• Albuquerque Neuroscience, Incorporated — Albuquerque, New Mexico, United States
• Social Psychiatry Research Institute — Brooklyn, New York, United States
• Trinity Health Organization — Minot, North Dakota, United States
• University of Cincinnati Medical Center — Cincinnati, Ohio, United States
• Radiant Research, — Columbus, Ohio, United States
• Midwest Clinical Research Center — Dayton, Ohio, United States
• Sunstone Medical Research, LLC — Medford, Oregon, United States
• Allegheny Pain Management — Altoona, Pennsylvania, United States
• East Penn RheumatologyAssociates, P.C. — Bethlehem, Pennsylvania, United States
• Clinical Research Associates, Inc. — Nashville, Tennessee, United States
• Andrew O. Schreiber, MD — Orange, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.